57 results
424B5
NTLA
Intellia Therapeutics Inc
26 Feb 24
Prospectus supplement for primary offering
7:04am
basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may … underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase on a standby basis. If we do not enter
424B5
NTLA
Intellia Therapeutics Inc
23 Feb 24
Prospectus supplement for primary offering
5:22pm
supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods … into a standby underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities
S-3ASR
tuzh7a yh
24 Nov 23
Automatic shelf registration
9:30am
PRE 14A
xi4cl
18 Apr 23
Preliminary proxy
4:16pm
424B5
rhz8 cvu58gxfnr3u7
1 Dec 22
Prospectus supplement for primary offering
5:09pm
424B5
7x3xha2x6bud sx3
4 Mar 22
Prospectus supplement for primary offering
5:03pm
424B5
k4eam8gs ecqm4rvz6
1 Jul 21
Prospectus supplement for primary offering
4:55pm
424B5
kf0wb
28 Jun 21
Prospectus supplement for primary offering
4:02pm
8-K
EX-99.1
715w8sok
22 Jun 21
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company
7:15am